Your Depression Feels Genetic. Because It Is.

SLC6A4 produces the serotonin transporter, a protein that sits on the surface of nerve cells and pulls serotonin back out of the space between neurons so it can be reused. Think of it as the recycling system for one of your brain’s most important mood chemicals. When this transporter works efficiently, serotonin gets reabsorbed and recycled, keeping mood stable and stress resilience high.

The 5-HTTLPR short allele variant, carried by roughly 40% of the population, reduces the efficiency of this recycling system. You produce the same amount of serotonin, but your brain recycles it less effectively, leaving lower serotonin available in the spaces between neurons. This isn’t a deficiency you can fix by eating more turkey or taking 5-HTP; it’s a structural limitation in how your cells reuse what they produce.

You experience this as persistent low mood, difficulty bouncing back from stress, heightened anxiety reactivity, and often a poor response to standard SSRIs (which work by blocking reabsorption, but you already have low serotonin circulation). You feel emotionally fragile in situations others seem to handle easily. Small setbacks hit harder and linger longer.

COMT is the enzyme that breaks down dopamine, norepinephrine, and epinephrine, the neurotransmitters responsible for focus, drive, and the stress response. When COMT works efficiently, you clear these chemicals at the right pace, staying calm under pressure while maintaining motivation. When it’s slow, these stress hormones linger in your system longer than they should.

The Val158Met variant creates two different versions of this enzyme. The slow version, found in roughly 25% of people with European ancestry as the homozygous form, processes stress hormones at a much slower rate. Your body is flooded with dopamine and norepinephrine during stress, and then they stick around for hours or days instead of minutes, keeping you in a heightened, reactive state. You’re not handling stress worse; you’re chemically unable to exit stress mode.

You experience this as persistent anxiety, emotional reactivity to small triggers, difficulty letting go of worry, and an intense sensitivity to caffeine and stimulants. You’re constantly in fight-or-flight, even when there’s no actual threat. Sleep feels fragmented because your stress hormones are still elevated when you’re trying to relax.

BDNF is brain-derived neurotrophic factor, a protein that acts like fertilizer for your neurons. It helps your brain form new connections, strengthen existing ones, and recover from damage. When BDNF levels are high, your brain is plastic and adaptable; therapy rewires you, exercise lifts your mood, and antidepressants have a better chance of working. When BDNF is low, your brain feels stuck.

The Val66Met variant, present in roughly 30% of the population, reduces how much BDNF your brain secretes. Your brain is literally less able to form new neural pathways, even when you’re doing all the right things in therapy and taking medication. You can sit through talk therapy, understand every insight intellectually, and still feel unchanged because the neural rewiring isn’t happening at the cellular level.

You experience this as treatment-resistant depression, where antidepressants plateau after a few weeks, therapy insights don’t seem to stick, and depression feels immovable despite your best efforts. You’re not therapy-resistant; your brain is operating with reduced capacity to change.

MAOA is the enzyme that breaks down serotonin, dopamine, and norepinephrine once they’ve done their job. It’s the cleanup system for your mood chemicals. When MAOA works at normal speed, you have stable neurotransmitter levels. When it’s slow, these chemicals accumulate and fluctuate dramatically, creating mood instability and heightened reactivity.

The MAOA-L (low activity) variant, present in roughly 30-40% of males, reduces how quickly this enzyme works. Your mood chemicals linger in your system longer than they should, creating periods of relative abundance followed by depletion, leading to mood swings and heightened sensitivity to stress. This isn’t depression from low serotonin; it’s depression from chaotic, unstable serotonin levels that your brain can’t regulate.

You experience this as mood volatility, intense emotional reactivity to environmental triggers, difficulty with impulse control, and a sense that your emotions are running you rather than the other way around. Small frustrations trigger disproportionate anger. You feel emotionally raw and exposed.

FKBP5 regulates how sensitive your glucocorticoid receptors are to cortisol, the stress hormone. When FKBP5 works normally, cortisol binds to its receptors, signals “stress is happening,” and then the system shuts down and returns to baseline. When FKBP5 is impaired, your stress response stays activated longer, and your cortisol levels don’t come back down when the threat passes.

The rs1360780 variant, present in roughly 30% of the population, impairs glucocorticoid receptor sensitivity. After a stressful event, your cortisol stays elevated for hours or days instead of returning to normal within minutes, keeping your nervous system in high alert. You’re not stressed because life is stressful; you’re stressed because your body physically cannot exit the stress response.

You experience this as persistent anxiety, difficulty sleeping despite exhaustion, a sense of impending doom even when things are fine, and depression that worsens after stressful events and takes weeks to recover. You’re hypervigilant. You anticipate problems before they exist. Recovery from setbacks feels slow.

MTHFR is the enzyme that converts folate into its active form, methylfolate, which is used in the methylation cycle. The methylation cycle produces neurotransmitters, repairs DNA, and manages inflammation. When MTHFR works efficiently, you have plenty of methylfolate available to synthesize serotonin, dopamine, and norepinephrine. When MTHFR is impaired, you have a functional folate deficiency at the cellular level.

The C677T variant, present in roughly 40% of people with European ancestry, reduces MTHFR enzyme activity by 35-40%. Your cells cannot efficiently convert folate into the active form, creating a functional deficiency even if your blood folate levels look normal. You have the raw ingredients but not the machinery to process them, leaving your brain without enough substrate to make mood chemicals.

You experience this as depression that doesn’t respond to standard supplementation, persistent brain fog, low mood, and often a tendency toward autoimmune issues. Your blood work looks fine but you feel chemically depleted. Other interventions (therapy, exercise, standard supplements) don’t move the needle because the bottleneck is at the methylation level.